Viewing Study NCT05029895


Ignite Creation Date: 2025-12-24 @ 2:19 PM
Ignite Modification Date: 2025-12-26 @ 10:45 AM
Study NCT ID: NCT05029895
Status: COMPLETED
Last Update Posted: 2025-12-23
First Post: 2021-08-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate Adverse Events and Change in Disease State of Oral Upadacitinib in Adolescent Participants Ages 12 to <18 Years Old Diagnosed With Atopic Dermatitis (AD)
Sponsor: AbbVie
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module